LPL Financial
PYXS icon

LPL Financial’s Pyxis Oncology PYXS Stock Holding History

LPL Financial’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Buy
43,554
+10,000
+30% +$19.1K ﹤0.01% 5868
2026
Q1 		$49K Sell
33,554
-1,548
-4% -$2.33K ﹤0.01% 5791
2025
Q4 		$40.4K Buy
35,102
+21,100
+151% +$74.4K ﹤0.01% 5727
2025
Q3 		$31.1K Sell
14,002
-197
-1% -$284 ﹤0.01% 5694
2025
Q2 		$15.6K Sell
14,199
-1,900
-12% -$2.14K ﹤0.01% 5496
2025
Q1 		$15.8K Sell
16,099
-6,500
-29% -$8.67K ﹤0.01% 5282
2024
Q4 		$35.3K Buy
22,599
+7,800
+53% +$22.5K ﹤0.01% 5143
2024
Q3 		$54.3K Buy
+14,799
New +$51.8K ﹤0.01% 4989
2024
Q1 		– Sell
-11,429
Closed -$20.6K – 5004
2023
Q4 		$20.6K Buy
+11,429
New +$19.6K ﹤0.01% 4730
2023
Q2 		– Sell
-13,664
Closed -$54.8K – 4662
2023
Q1 		$54.8K Buy
+13,664
New +$27.3K ﹤0.01% 4291

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's PYXS Position: Q2 2026 in Review

LPL Financial increased its Pyxis Oncology (PYXS) stake by 30% in Q2 2026, buying an estimated $19.1K and bringing the position to 43,554 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #5868.

LPL Financial first reported a position in PYXS in Q1 2023 and has held it in 10 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • LPL Financial held 43,554 shares of Pyxis Oncology worth $131K as of Q2 2026.
  • LPL Financial bought 10,000 Pyxis Oncology shares in Q2 2026, an estimated $19.1K.
  • Pyxis Oncology made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5868 holding.
  • LPL Financial first reported a position in Pyxis Oncology in Q1 2023 and has held it in 10 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.